Gottlieb, R. L., Clement, M., Cook, P., Deveikis, A., Foong, K. S., Robinson, P., Slim, J., Spak, C. W., Annemie Buelens, Callewaert, K., Meyer, S. D., Mo, W. L., Verbrugge, I., Liesbeth Van Wesenbeeck, Zhuang, Y., Chien, J. W., Opsomer, M., & Landuyt, E. V. (2024). The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19. Journal of Infection, 89(4), 106241–106241. https://doi.org/10.1016/j.jinf.2024.106241
